Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene

scientific article published on 01 July 1994

Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7920209

P2093author name stringKadlubar FF
Shin S
Yokoi T
Nakajima M
Kamataki T
Mizutani M
P433issue5
P921main subjectphenotypeQ104053
P304page(s)413-421
P577publication date1994-07-01
P1433published inCancer Epidemiology, Biomarkers & PreventionQ326334
P1476titlePhenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene
P478volume3

Reverse relations

cites work (P2860)
Q33322926Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris
Q36063995Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans
Q56795476Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls
Q37001556Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers
Q24806052Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study
Q55043253Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
Q47771449Determination of -3858G-->A and -164C-->A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G-->A mutation between Caucasians and Asians
Q35039136Differential pharmacokinetics of theophylline in elderly patients
Q33700123Drug interactions with tobacco smoking. An update
Q58615950Effects of Common CYP1A2 Genotypes and other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: an Exploratory Analysis
Q35036312Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia.
Q41593416Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
Q37286958Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer
Q41908761Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis
Q36807462Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population
Q39042845Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population
Q41172369Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism
Q46359082Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism
Q41073233Molecular basis of polymorphic drug metabolism
Q30886181Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity
Q24811520PCB exposure and in vivo CYP1A2 activity among Native Americans
Q34534425Pharmacogenetics of asthma
Q46872878Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy
Q36055051Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population
Q48577324Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study.
Q42284296Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Q34834089Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research
Q36053773Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo
Q36055087The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.

Search more.